Organization: Merck Canada

CATALIS welcomes new partners

The CATALIS Quebec Clinical Trials initiative has announced new public partners and industry funding as it moves closer to its goal of doubling private sector investment in the province’s early stage clinical trials (ESCT) and providing patients early access to innovative healthcare.

Three CECRs receive $4 million from Merck Canada

Merck Canada is investing $4 million in three Centres of Excellence for Commercialization and Research (CECR) as part of a $100-million commitment it made in 2010 when it closed its Merck Frosst Centre for Therapeutic Research in a global restructuring (R$, July 19/10). The funding goes to the Institute for Research in Immunology and Cancer…

Merck invests in $12.5 million in three research institutions

Merck Canada is investing $12.5 million in three Montreal-based university- and hospital-affiliated research institutions as part of its $100-million commitment to the province, announced when it decided to shutter the Merck Frosst Centre for Therapeutic Research (R$, July 19/10). The funding will be invested in the McGill University Health Centre, the University of Montreal Hospital…

Merck commits $5 million to Quebec’s CQDM

Merck Canada is investing a further $5 million over five years in the Quebec Consortium for Drug Discovery (CQDM), a not-for-profit organization of which Merck is a founding member (R$, June 20/08). The investment is part of a 2010 pledge Merck made to support Quebec-based R&D, which coincided with its decision to shutter its Merck…